Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets

OBJECTIVE: The off-target effects and severe side effects of PPARα and LXRα agonists greatly limit their application in atherosclerosis (AS). Therefore, this study intended to use mesoporous silica nanoparticles as carriers to generate MnO nanoparticles in situ with T1WI-MRI in mesoporous pores and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Lv, Zheng, Zhang, Yupeng, Gopinath, Subash C. B., Yuan, Yi, Huang, Deyou, Miao, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537012/
https://www.ncbi.nlm.nih.gov/pubmed/36211824
http://dx.doi.org/10.1155/2022/6006601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537012/
https://www.ncbi.nlm.nih.gov/pubmed/36211824
http://dx.doi.org/10.1155/2022/6006601

Ejemplares similares